Marketbeat

Published September 21, 2026 · Updated September 22, 2026

Cybin Eyes Q4 Phase III Depression Readout as Psychedelic Pipeline Advances

Read the full story at Marketbeat

Cybin Inc is a clinical-stage biopharmaceutical company focused on developing psychedelic ... These 3 Biotech Stocks Have MAJOR Catalysts Coming (Get in.